Stock Analysis on Net
Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

$24.99

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

Try for free

Johnson & Johnson pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Johnson & Johnson, consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019
Net earnings (loss)
Depreciation and amortization of property and intangibles
Stock based compensation
Asset write-downs
Charge for purchase of in-process research and development assets
Gain on Kenvue separation
Contingent consideration reversal
Net gain on sale of assets/businesses
Deferred tax provision
Credit losses and accounts receivable allowances
(Increase) decrease in accounts receivable
(Increase) decrease in inventories
Increase (decrease) in accounts payable and accrued liabilities
(Increase) decrease in other current and non-current assets
Increase (decrease) in other current and non-current liabilities
Changes in assets and liabilities, net of effects from acquisitions and divestitures
Adjustments to reconcile net earnings (loss) to cash flows from operating activities
Net cash flows from operating activities
Additions to property, plant and equipment
Proceeds from the disposal of assets/businesses, net
Acquisitions, net of cash acquired
Purchases of in-process research and development assets
Purchases of investments
Sales of investments
Credit support agreements activity, net
Other, including capitalized licenses and milestones
Net cash (used by) from investing activities
Dividends to shareholders
Repurchase of common stock
Proceeds from short-term debt, net
Repayment of short-term debt, net
Proceeds from long-term debt, net of issuance costs
Repayment of long-term debt
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net
Credit support agreements activity, net
Settlement of convertible debt acquired from Shockwave
Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to Kenvue at separation
Proceeds from Kenvue initial public offering
Cash transferred to Kenvue at separation
Other
Net cash from (used by) financing activities
Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents

Based on: 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-27), 10-Q (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29), 10-K (reporting date: 2019-12-29), 10-Q (reporting date: 2019-09-29), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Cash flow statement item Description The company
Net cash flows from operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Johnson & Johnson net cash flows from operating activities increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Net cash (used by) from investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Johnson & Johnson net cash (used by) from investing activities decreased from Q1 2024 to Q2 2024 but then increased from Q2 2024 to Q3 2024 not reaching Q1 2024 level.
Net cash from (used by) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Johnson & Johnson net cash from (used by) financing activities increased from Q1 2024 to Q2 2024 but then decreased significantly from Q2 2024 to Q3 2024.